aTyr Pharma Added To Russell 2000®, 3000® And Global Indexes
June 29, 2015aTyr Pharma has been added to Russell 2000®, Russell 3000® and Russell Global Indexes as part of Russell Investments' annual reconstitution. Russell indexes are used by investment managers and institutional investors for index funds and as benchmarks for
More »
BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date
June 29, 2015A study by BioNano Genomics and Icahn School of Medicine at Mount Sinai was published in Nature Methods describing the creation of the first comprehensive analysis of a diploid human genome using two complementary single DNA molecule methods for sequencin
More »
Sebacia Announces Series C Financing to Advance Innovative Dermatology Treatment for Acne
June 25, 2015Sebacia completes a $22M Series C financing, $12M in equity from existing investors including Domain. With the proceeds, they plan to complete their pivotal U.S. clinical trial and the application to the FDA to register the Sebacia Treatment as a medical
More »